MyAverix Finance
US · Healthcare
Neuraxis, Inc. (NRXS)
Biotechnology
Neuraxis, Inc. (NRXS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NRXS
Neuraxis, Inc. (NRXS) — FAQ
What is NRXS's P/E ratio?
The price-to-earnings (P/E) ratio for Neuraxis, Inc. (NRXS) is 25.00 (data as of 2026-05-23).
Does Neuraxis, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Neuraxis, Inc. (NRXS). Check the MyAverix Finance app for the latest dividend data.
What sector is Neuraxis, Inc. in?
Neuraxis, Inc. (NRXS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is NRXS listed on?
NRXS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.